M, Q., G, D., M, H., SS, M., V, P., E, N., . . . RA, B. (2024). When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis. CNS drugs, 38(9), 671. https://doi.org/10.1007/s40263-024-01100-4
Chicago Style (17th ed.) CitationM, Qubad, Dupont G, Hahn M, Martin SS, Puntmann V, Nagel E, Reif A, and Bittner RA. "When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis." CNS Drugs 38, no. 9 (2024): 671. https://doi.org/10.1007/s40263-024-01100-4.
MLA (9th ed.) CitationM, Qubad, et al. "When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis." CNS Drugs, vol. 38, no. 9, 2024, p. 671, https://doi.org/10.1007/s40263-024-01100-4.
Warning: These citations may not always be 100% accurate.